Falcone E Liana, Mangili Alexandra, Skinner Sally, Alam Ahsan, Polak Joseph F, Wanke Christine A
Department of Medicine, Tufts Medical Center, Boston, MA, USA.
Antivir Ther. 2011;16(1):1-8. doi: 10.3851/IMP1682.
The utility of the Framingham risk score among individuals infected with HIV is poorly understood. We examined the association of Framingham risk scores with surrogate markers of atherosclerosis in a carefully characterized cohort of adults infected with HIV.
We calculated Framingham risk scores and measured carotid intima-media thickness (c-IMT) and coronary artery calcium (CAC) scores in 334 participants from the Nutrition for Healthy Living study. Cardiovascular risk factors, c-IMT and CAC scores were assessed for each Framingham risk subgroup (low versus intermediate/high risk). We used adjusted and unadjusted linear and logistic regression to examine the association between clinical factors and Framingham risk group with c-IMT and CAC scores.
Patients with intermediate/high Framingham risk scores were more likely to have internal c-IMT ≥ 1.0 mm (26% versus 12%; P=0.003) and common c-IMT ≥ 0.8 mm (22% versus 5%; P < 0.001). These patients were also more likely to have detectable CAC (78% versus 48%; P < 0.001). Intermediate/high Framingham risk scores were significantly associated with internal c-IMT ≥ 1.0 mm (odds ratio 2.65 [95% confidence interval 1.37-5.13]) and common c-IMT ≥ 0.8 mm (odds ratio 5.24 [95% confidence interval 2.39-11.50]). Intermediate/high Framingham risk scores were also significantly associated with detectable CAC (odds ratio 3.84 [95% confidence interval 2.05-7.16]). The addition of HIV-related variables did not improve the accuracy of the Framingham risk score.
Our study shows that increased Framingham risk scores are associated with abnormal early and late surrogate markers of atherosclerosis in adults infected with HIV, and might predict the risk of cardiovascular complications in this population.
人们对弗雷明汉风险评分在感染HIV个体中的效用了解甚少。我们在一组经过精心特征描述的成年HIV感染者队列中,研究了弗雷明汉风险评分与动脉粥样硬化替代标志物之间的关联。
我们计算了来自“健康生活营养研究”的334名参与者的弗雷明汉风险评分,并测量了颈动脉内膜中层厚度(c-IMT)和冠状动脉钙化(CAC)评分。针对每个弗雷明汉风险亚组(低风险与中/高风险)评估心血管危险因素、c-IMT和CAC评分。我们使用调整和未调整的线性及逻辑回归,来研究临床因素和弗雷明汉风险组与c-IMT和CAC评分之间的关联。
弗雷明汉风险评分为中/高的患者更有可能出现内膜c-IMT≥1.0毫米(26%对12%;P = 0.003)以及颈总c-IMT≥0.8毫米(22%对5%;P < 0.001)。这些患者也更有可能检测到CAC(78%对48%;P < 0.001)。弗雷明汉风险评分为中/高与内膜c-IMT≥1.0毫米(优势比2.65 [95%置信区间1.37 - 5.13])和颈总c-IMT≥0.8毫米(优势比5.24 [95%置信区间2.39 - 11.50])显著相关。弗雷明汉风险评分为中/高也与可检测到的CAC显著相关(优势比3.84 [95%置信区间2.05 - 7.16])。加入与HIV相关的变量并未提高弗雷明汉风险评分的准确性。
我们的研究表明,弗雷明汉风险评分升高与成年HIV感染者动脉粥样硬化的早期和晚期异常替代标志物相关,并且可能预测该人群心血管并发症的风险。